Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Neuropathic Pain: What It Is, How It’s Diagnosed, How It’s Treated By Scott Millard November 20, 2018 Consulting Ashanthi DeSilva’s Story: A Look Back at the First Gene Therapy Trial By Juliet Moritz November 14, 2018 Medical and Regulatory Affairs The Evolution of Regulations for Digital Health Products By Nach Davé November 5, 2018 Medical and Regulatory Affairs Draft Guidance: Hematologic Malignancies: Regulatory Considerations for Use of Minimal Residual Disease in Development of Drug and Biological Products for Treatment By Premier Research November 5, 2018 New Research Highlights the Challenges of Studying Alzheimer’s Disease By Andreas Schreiner October 30, 2018 Medical and Regulatory Affairs 5 Reasons to Consider APAC for Clinical Trials By Ashish Jain October 17, 2018 Previous 1 …27 28 29 30 31 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today